FDA officials offer CMC advice for gene therapies at OTP town hall
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyChemistry, Manufacturing and Controls (CMC)North AmericaPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/Policy